Assess the regulatory gap
Organise the product, dossier, manufacturing-site and lifecycle questions that need a documented assessment before a submission plan is agreed.
Explore regulatory affairs →Connect your pharmaceutical, biotechnology or medtech programme to a clear plan for the UAE, Saudi Arabia and wider GCC. Bring scientific evidence, regulatory readiness, market access and operational delivery into one conversation.
Find your country and language ↓HERMS combines specialist workflows with its connected intelligence platform. The right starting point depends on your product, existing evidence, intended markets and delivery model.
Organise the product, dossier, manufacturing-site and lifecycle questions that need a documented assessment before a submission plan is agreed.
Explore regulatory affairs →Connect your value story, pricing assumptions, evidence needs and intended launch sequence to a GCC market-access discussion.
Explore pricing and market access →Bring pharmacovigilance, compliance, quality, supply-chain and partner responsibilities into the operating model from the beginning.
Explore the connected solutions →Choose a language to explore HERMS, or begin a GCC programme discussion from your country. These links describe the intended audience; HERMS is based in Dubai, UAE.
Language links open the existing HERMS website editions. Programme scope, working language and delivery arrangements are agreed during scoping.
A useful starting brief contains six items. Share non-confidential information first; agree a suitable confidentiality arrangement before exchanging sensitive programme material.
For advanced therapies, explore GENIX and CELLIX. For innovation screening and diligence, explore VALNEXIS and VERIQIS. For transfer and manufacturing workflows, explore INNEXIS and SYNTRIX.
Find the relevant HERMS solution →Review the questions behind a credible timeline, including product classification, evidence readiness and dependencies.
Read the registration-planning guide →Connect the proposed product value to the commercial and evidence questions your launch team needs to resolve.
Read the market-access guide →Discuss scientific, technology, implementation and commercial collaboration with HERMS.
Explore partnerships →ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.
We use essential cookies to run this website and, with your consent, analytics cookies to improve it. You can change your choice at any time. Cookie Policy · Privacy Policy
HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.